Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Imeglimin

Imeglimin

Imeglimin structure

Imeglimin 

structure
  • CAS No:

    775351-65-0

  • Formula:

    C6H13N5

  • Chemical Name:

    Imeglimin

  • Synonyms:

    1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL;1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, (6R)-;Emd 387008 hcl

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Imeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.


Imeglimin is an oral anti-diabetic drug discovered by Poxel and co-developed with Sumitomo Dainippon Pharma. In 2021, Imeglimin was approved in Japan for the treatment of type 2 diabetes (T2D).

Imeglimin Basic Attributes

155.2

155.20

UU226QGU97

DTXSID50228237

Characteristics

1.29±0.1 g/cm3(Predicted)

239.9±23.0 °C(Predicted)

11.65±0.40(Predicted)

Store at -20°C

Drug Information

imeglimin

Imeglimin Use and Manufacturing

Imeglimin (EMD 387008) is an oral glucose-lowering agent. Imeglimin improves insulin sensitivity. Imeglimin also reduces reactive oxygen species (ROS) production, increases mitochondrial DNA and improves mitochondrial function[1].

Recommended Suppliers of Imeglimin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.